|
"pol s"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-09-04T06:11:39Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti M.; Flisiak R.; JIA-HORNG KAO; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns, M.;Pol, S.;Jacobson, I.M.;Marcellin, P.;Gordon, S.C.;Peng, C.-Y.;Chang, T.-T.;Everson, G.T.;Heo, J.;Gerken, G.;Yoffe, B.;Towner, W.J.;Bourliere, M.;Metivier, S.;Chu, C.-J.;Sievert, W.;Bronowicki, J.-P.;Thabut, D.;Lee, Y.-J.;Kao, J.-H.;Mcphee, F.;Kopit, J.;Mendez, P.;Linaberry, M.;Hughes, E.;Noviello, S.; JIA-HORNG KAO |
| 國立成功大學 |
2018 |
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis
|
Puoti, M.;Foster, G.R.;Wang, S.;Mutimer, D.;Gane, E.;Moreno, C.;Chang, T.T.;Lee, S.S.;Marinho, R.;Dufour, J.-F.;Pol, S.;Hezode, C.;Gordon, S.C.;Strasser, Strasser S.I.;Thuluvath, P.J.;Zhang, Zhang Z.;Lovell, S.;Pilot-Matias, T.;Mensa, F.J. |
| 中國醫藥大學 |
2014-11 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
(Manns M)*;(Pol S);(Jacobson IM);(Marcellin P);(Gordon SC);彭成元(Cheng-Yuan Peng);(Chang TT);(Everson GT);(Heo J);(Gerken G);(Yoffe B);(Towner WJ);(Bourliere M);(Metivier S);(Chu CJ);(Sievert W);(Bronowicki JP);(Thabut D);(Lee YJ);(Kao JH);(McPhee F);(Kopit J);(Mendez P);(Linaberry M);(Hughes E);(Noviello S) |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
